Bourla said he has received four shots of Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech.
- The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.
Chairman and CEO Albert Bourla said that he started taking Pfizer’s Paxlovid pill treatment, and he’s staying in isolation while he recovers. Bourla said Monday in a brief statement from the drugmaker that he has received four shots of Comirnaty, the COVID-19 vaccine developed by both Pfizer and German drugmaker BioNTech, and he is confident that he will recover quickly.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
A Utah singer works to keep alive the legacy of her partner, who died from COVID-19More than a year after Smith’s untimely death from COVID-19, Olivo is releasing music they made together — to keep his legacy and their collaboration alive.
Lire la suite »
UK Becomes the First Country to Approve a Dual Covid Vaccine Targeting OmicronBritain on Monday became the first country in the world to approve a dual Covid-19 vaccine, which tackles both the original virus and the newer Omicron variant.
Lire la suite »
Moderna's vaccine that targets the omicron variant gets its first approval after authorized by British regulatorsBritish drug regulators become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant.
Lire la suite »
How to Assess Covid-19 Risks After Easing of CDC GuidelinesThe easing of federal Covid-19 guidelines places more responsibility on individuals. Here is what doctors recommend.
Lire la suite »
BCG Vaccine for Tuberculosis Offers Covid-19 Protection, Study SuggestsA widely used tuberculosis vaccine protected people with type 1 diabetes from Covid-19, according to a study, further illustrating the potential immune-enhancing powers of the BCG shot
Lire la suite »